Professor of Obstetrics and Gynecology, UCLA
Obstetrics & Gynecology
Dr. Andrea J. Rapkin, MD
|
|
Give Review
Andrea Rapkin is an expert in the field of Obstetrics & Gynecology. She graduated from University at Buffalo, School of Medicine and Biomedical Sciences. She over the years received 4 awards: "CMS Meaningful Use Stage 1 Certification", "Top Doctors:LA Area", "Fellow (FACOG)" and "Super Doctor". Doctor Andrea J. Rapkin, MD is a published doctor. She has 76 publications published. The most current publication "Insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 in women with premenstrual syndrome." Andrea J. Rapkin, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- Pain Catastrophizing Predicts Menstrual Pain Ratings in Adolescent Girls with Chronic Pain.
- Treatment of preMenstrual dysphoric disorder.
- ISPMD consensus on the management of preMenstrual disorders.
- Elevated gray matter volume of the emotional cerebellum in women with preMenstrual dysphoric disorder.
- PreMenstrual Dysphoric Disorder and Severe PreMenstrual Syndrome in Adolescents : Diagnosis and Pharmacological Treatment.
- Cognitive flexibility, reaction time, and attention in women with preMenstrual dysphoric disorder.
- Reproductive events modify the effects of estrogen replacement therapy on cognition in healthy PostMenopausal women.
- A review of treatment of preMenstrual syndrome and preMenstrual dysphoric disorder.
- Effect of an oral contraceptive containing ethinyl estradiol and drospirenone on preMenstrual symptomatology and health-related quality of life.
- Efficacy of a new low-dose oral contraceptive with drospirenone in preMenstrual dysphoric disorder.
- Clinical diagnostic criteria for preMenstrual syndrome and guidelines for their quantification for research studies.
- The same dorsal root ganglion neurons innervate uterus and colon in the rat.
- Estrogen and response to sertraline in PostMenopausal women with major depressive disorder: a pilot study.
- Inflammation in the uterus induces phosphorylated extracellular signal-regulated kinase and substance P immunoreactivity in dorsal root ganglia neurons innervating bot...
- Clitoral and vulvar vestibular sensation in women taking 20 mcg ethinyl estradiol combined oral contraceptives: a preliminary study.
- Treatment of metronidazole-resistant Trichomonas Vaginalis.
- Estradiol attenuates the adenosine triphosphate-induced increase of intracellular calcium through group II metabotropic glutamate receptors in rat dorsal root ganglion...
- Diagnosis and management of preMenstrual disorders.
- Ethinyl estradiol 20μg/drospirenone 3mg 24/4 oral contraceptive for the treatment of functional impairment in women with preMenstrual dysphoric disorder.
- Towards a consensus on diagnostic criteria, measurement and trial design of the preMenstrual disorders: the ISPMD Montreal consensus.
- Continuous oral levonorgestrel/ethinyl estradiol for treating preMenstrual dysphoric disorder.
- Neuroimaging evidence of cerebellar involvement in preMenstrual dysphoric disorder.
- Ethinyl estradiol/drospirenone for the treatment of the emotional and physical symptoms of preMenstrual dysphoric disorder.
- Neuroactive steroids after estrogen exposure in depressed postmenopausal women treated with sertraline and Asymptomatic postmenopausal women.
- PreMenstrual syndrome and preMenstrual dysphoric disorder: quality of life and burden of illness.
- YAZ in the treatment of preMenstrual dysphoric disorder.
- PreMenstrual syndrome and preMenstrual dysphoric disorder in adolescents.
- Drospirenone/ethinyl estradiol.
- The pharmacologic management of preMenstrual dysphoric disorder.
- Multilevel local anesthetic nerve blockade for the treatment of vulvar vestibulitis syndrome.
- Drospirenone: a novel progestin.
- PreMenstrual syndrome in adolescents: diagnosis and treatment.
- Decreased neuroactive steroids induced by combined oral contraceptive pills are not associated with mood changes.
- New treatment approaches for preMenstrual disorders.
- Vasomotor symptoms in Menopause: physiologic condition and central nervous system approaches to treatment.
- Oral contraceptives and neuroactive steroids.
- Neurophysiologic changes during estrogen augmentation in perimenopausal depression.
- Treatment of preMenstrual disorders.
- Diagnosis of preMenstrual disorders.
- PreMenstrual disorders: prevalence, etiology and impact.
- Relationships among self-rated tanner staging, hormones, and psychosocial factors in healthy Female adolescents.
- Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study.
- The Pains of endometriosis.
- Gynecological health of Females with congenital heart disease.
- The clinical nature and formal diagnosis of preMenstrual, postpartum, and perimenopausal affective disorders.
- Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women.
- Evaluation of a unique oral contraceptive in the treatment of preMenstrual dysphoric disorder.
- Neuroactive steroid-serotonergic interaction: responses to an intravenous L-tryptophan challenge in women with preMenstrual syndrome.
- Menstrual cycle-related brain metabolite changes using 1H magnetic resonance spectroscopy in premenopausal women: a pilot study.
- Peritoneal fluid interleukin-6 in women with Chronic pelvic pain.
- Neuroendocrine response to an intravenous L-tryptophan challenge in women with preMenstrual syndrome.
- Insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 in women with preMenstrual syndrome.
- Progesterone metabolite allopregnanolone in women with preMenstrual syndrome.
- Cognitive functioning in preMenstrual syndrome.
- Decreased central opioid activity in preMenstrual syndrome: luteinizing hormone response to naloxone.
- Gastroenterologic causes of Chronic pelvic pain.
- Menstrual cycle and social behavior in vervet monkeys.
- Menstrual patterns in women with congenital heart disease.
- Whole-blood serotonin in preMenstrual syndrome.
- Non-availability of the IUD and contraceptive choice.
- Comparison of retrospective and prospective assessment of preMenstrual symptoms.
- Platelet monoamine oxidase B activity in women with preMenstrual syndrome.
- Pruritic vulvar squamous papillomatosis: evidence for Human papillomavirus etiology.
- Adhesions and Pelvic pain: a retrospective study.
- Mood and cognitive style in preMenstrual syndrome.
- Peritoneal fluid eicosanoids in Chronic pelvic pain.
- The pain management approach to Chronic pelvic pain.
- Menstrual patterns in Females after the Fontan repair.
- History of physical and sexual abuse in women with Chronic pelvic pain.
- Effectiveness of an interdisciplinary pain management program for the treatment of Chronic pelvic pain.
- Differences in knowledge of and risk factors for AIDS between Hispanic and non-Hispanic women attending an urban family planning clinic.
- Neuroanatomy, neurophysiology, and neuropharmacology of Pelvic pain.
- Unwanted sexual experiences among middle and high school youth.
- Tryptophan and neutral amino acids in preMenstrual syndrome.
- The role of serotonin in preMenstrual syndrome.
Schools
U OF BUFFALO SUNY SCH OF MED amp BIOMEDICAL SCI
SUNY Buffalo Affil HspObg
UCLA Med Center
Procedures Preformed
- Colposcopy
- Contraceptive Management
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- Endocervical Curettage
- View All
Conditions Treated
- Asymptomatic Post-Menopausal Status
- Atrophic Vaginitis
- Carcinoma in Situ
- Cervical Cancer
- View All
Doctors Specialties
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Top Doctors:LA Area
- Fellow (FACOG)
- Super Doctor
Education
-
UCLA Medical Center -
University at Buffalo, School of Medicine and Biomedical Sciences
Hospital
-
Ronald Reagan UCLA Medical Center -
Santa Monica-UCLA Medical Center and Orthopaedic Hospital
Drug Facts
| NPI NUMBER | 1720013485 | |
| NPPES Provider LastName | RAPKIN | |
| NPPES Provider FirstName | ANDREA | |
| NPPES Provider ZIPCode | 900950001 | |
| NPPES Provider State | CA | |
| Specialty Description | Obstetrics/Gynecology | |
| Total Claim Count | 481.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 14.0 | |
| Percent Opioid Claims | 2.91 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1720013485 |
| Last Name Of The Provider | RAPKIN |
| First Name Of The Provider | ANDREA |
| View All |
Similar Doctors
|
|
Dr. Ezra C. Davidson Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathon M. Solnik, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sebhat Afework, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Parviz Mazahery, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian A. Miyazaki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hasti M. Poya, MD
This Doctor is OpenDoctor Recommended.
|